Username Password
S&P 500: 1,948.86
Change: +1.83%

BIOGEN IDEC INC (BIIB)

Overview
Price 304.21
Price Change Today +$11.71 (+4.00%)
P&P rating Rating: 4
Open Price $298.48
Previous Close $292.50
Daily Range $293.61 - $304.43
52-Week Range $265.00 - $480.18
Volume 2
chart
Top Buy Analysis
BUY: BIIB Rating: 4
Company: BIOGEN IDEC INC
Points: 167.77
Start Price: $97.34
Start Date: 05/09/2011 11:45 PM
Neurodoc
Neurodoc
P&P Score: 99.64
Recs:
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Top Sell Analysis
No Sell Analysis. Be the First.
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

50 Buy
0 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.96 12/23/14 BioTECH and Pharma / Drug manufactures being sold 1 12/23/14
rjm77me
99.96 07/23/14 If you have 100 stocks to watch during earning season = How will you track it 11 07/26/14
rjm77me
99.96 07/21/14 Zacks list of potential earning Beaters 6 07/24/14
rjm77me
99.96 04/24/14 Bio Tech leaders had lack luster earning results = $BIIB, AMGN, CELG 0
rjm77me
99.96 03/24/14 Charts, Stock Valuations some times have big divergences, In the end fundamentals have major influence 8 03/25/14
rjm77me
99.96 03/21/14 Momentum and Bio Tech on sale today 7 03/28/14
rjm77me
99.96 02/07/14 Is market ready to fly higher = coin toss between 2% gain or loss 0
rjm77me
99.96 11/07/13 Momentum stocks taken to wood shed today 4 11/20/13
rjm77me
99.96 06/12/13 $IBB head shoulder pattern confirmed 0
rjm77me
99.96 04/15/13 This was not a normal buy on pull back = it was a distribution day 3 04/21/13
Pages: [ 1 ]  2   3   4   5   ...  35  >>
Commentary
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +75.53
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +63.57
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +75.53
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +63.57
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +75.53
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +63.57
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +167.77
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +155.95
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +167.77
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +155.95
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
JDShots 0.55 BUY One to Three Months 05/15/2012 $137.04 $304.21
(+4.00%)
+121.99% +46.46% +75.53 view
JDShots 0.55 BUY One to Three Months 05/15/2012 $137.04 $304.21
(+4.00%)
+121.99% +58.41% +63.57 view
JDShots 0.55 BUY One to Three Months 05/15/2012 $137.04 $304.21
(+4.00%)
+121.99% +46.46% +75.53 view
JDShots 0.55 BUY One to Three Months 05/15/2012 $137.04 $304.21
(+4.00%)
+121.99% +58.41% +63.57 view
JDShots 0.55 BUY One to Three Months 05/15/2012 $137.04 $304.21
(+4.00%)
+121.99% +46.46% +75.53 view
JDShots 0.55 BUY One to Three Months 05/15/2012 $137.04 $304.21
(+4.00%)
+121.99% +58.41% +63.57 view
vip 53.73 BUY One to Three Months 01/26/2012 $117.85 $304.21
(+4.00%)
+158.13% +47.82% +110.32
vip 53.73 BUY One to Three Months 01/26/2012 $117.85 $304.21
(+4.00%)
+158.13% +59.88% +98.25
vip 53.73 BUY One to Three Months 01/26/2012 $117.85 $304.21
(+4.00%)
+158.13% +47.82% +110.32
vip 53.73 BUY One to Three Months 01/26/2012 $117.85 $304.21
(+4.00%)
+158.13% +59.88% +98.25
Pages: [ 1 ]  2   3   4   5  >>
Sponsored Links